Oxford Biomedica Plc (OXB.L) said on Wednesday that its Chief Financial Officer, Stuart Paynter, will resign with effect from September 2.
The company has appointed Lucinda (Lucy) Crabtree as successor of Paynter with effect from the same day.
Crabtree was previously CFO at MorphoSys AG. Prior to MorphoSys, she was Finance Chief of Autolus Therapeutics.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.